IXHL · NASDAQ · Biotechnology

Incannex Healthcare

Develops combination medicines and a psilocybin-assisted therapy candidate for chronic diseases.

$3.66
After-hours close+0.01 (+0.27%)
At close$3.65(−1.08%)
DateEstimateReportedSurprise
Oct 2026−$0.14
May 2026−$0.60−$0.35+41.7%
Feb 2026−$0.60−$0.600.0%
Nov 2025−$11.70−$0.60+94.9%
Sep 2025$0.00−$0.57

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
May 2025
Feb 2025
Nov 2024
Sep 2024
May 2024
Mar 2024
Feb 2024
Dec 2023
Sep 2023
Aug 2023
Mar 2023
Feb 2023
Dec 2022
Sep 2022
Sep 2022
Mar 2022
Feb 2022
Dec 2021
Sep 2021
Aug 2021
Jun 2021
Mar 2021
Feb 2021
Dec 2020
Sep 2020
Aug 2020
Jun 2020
Feb 2020
Dec 2019
Sep 2019
Jun 2019
Mar 2019
Dec 2018
Sep 2018
Jun 2018
Mar 2018
Dec 2017
Sep 2017
Jun 2017
Mar 2017
Dec 2016
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Oct 5, 2026−$0.14$200.0K
May 15, 2026−$0.60−$0.35+41.7%$200.0K
Feb 13, 2026−$0.60−$0.600.0%$200.0K
Nov 14, 2025−$11.70−$0.60+94.9%$200.0K
Sep 29, 2025$0.00−$0.57$200.0K$200.0K0.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
May 15, 2025
Feb 14, 2025
Nov 14, 2024
Sep 30, 2024
May 15, 2024
Mar 1, 2024
Feb 14, 2024
Dec 1, 2023
Sep 29, 2023
Aug 30, 2023
Mar 30, 2023
Feb 27, 2023
Dec 31, 2022
Sep 30, 2022
Sep 2, 2022
Mar 31, 2022
Feb 28, 2022
Dec 31, 2021
Sep 30, 2021
Aug 30, 2021
Jun 30, 2021
Mar 31, 2021
Feb 25, 2021
Dec 31, 2020
Sep 30, 2020
Aug 14, 2020
Jun 30, 2020
Feb 28, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018
Dec 31, 2017
Sep 30, 2017
Jun 30, 2017
Mar 31, 2017
Dec 31, 2016